Patented Technology
Introducting ImmunoGenes IMG-AbS™, a FcRn technology using genetically modified animals that overexpress the neonatal Fc Receptor (FcRn).
Customized Solutions
Our patented technology allows us to produce high quality and diverse antibodies against extremely challenging antigens.
Research Articles
ImmunoGenes is the leader in developing transgenic concepts based on published research by experienced scientists.